Mucolife
1 known investors
Find your way into Mucolife
341 people in our graph share verified history with the Mucolife team — schools, employers, funds. One of them is your warm intro.
Mike Zakunlockedknows Thaher Pelaseyed · together at Cornell (overlapped)
×9knows the team · via Cornell
knows the team · via University of Gothenburg
knows the team · via School of Business, Economics and Law at the University of Gothenburg
MucoLife Therapeutics develops treatments for pulmonary mucus obstruction associated with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Its lead product is a mucus modulator designed to dissolve mucus plugs obstructing the airways.
Founders & leadership
TP
Thaher PelaseyedinCo-founder & Chief Executive OfficerThaher Pelaseyed is co-founder and CEO of MucoLife Therapeutics, a company developing mucus-modulating treatments for COPD and cystic fibrosis. He has over 20 years of research experience in cell and mucin biology, including work at the Mucin Biology Group at University of Gothenburg, where his research has focused on transmembrane mucins and epithelial cell defense mechanisms.
GC
Gunnar C. HanssoninCo-founder & Chief Scientific Officer
KJ
Kicki JohanssoninChief Development Officer
MK
Maarten KraaninChief Clinical Officer
JS
Jim ShafferinChief Business Officer
Investors · 1
Frequently asked questions
- What does Mucolife do?
- MucoLife Therapeutics develops treatments for pulmonary mucus obstruction associated with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Its lead product is a mucus modulator designed to dissolve mucus plugs obstructing the airways.
- Who founded Mucolife?
- Mucolife was founded by Thaher Pelaseyed, Gunnar C. Hansson.
- Who are Mucolife's investors?
- Mucolife's investors include Health Wildcatters.